Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum

Abstract

Combination of platinum derivates with paclitaxel is currently the standard front line regimen for patients with epithelial ovarian carcinoma and represents also an active regimen in patients with metastatic breast or unknown primary carcinomas.

Keywords

• intestinal permeability
• cytotoxic therapy